These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15962606)

  • 1. [Effect of orlistat therapy on carbohydrate, lipid, vitamin and hormone plasma levels in obese subjects].
    Czerwieńska B; Kokot F; Franek E; Irzyniec T; Wiecek A
    Pol Arch Med Wewn; 2004 Dec; 112(6):1415-23. PubMed ID: 15962606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia.
    Lucas CP; Boldrin MN; Reaven GM
    Am J Cardiol; 2003 Apr; 91(8):961-4. PubMed ID: 12686336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
    Finer N; James WP; Kopelman PG; Lean ME; Williams G
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):306-13. PubMed ID: 10757623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.
    Tong PC; Lee ZS; Sea MM; Chow CC; Ko GT; Chan WB; So WY; Ma RC; Ozaki R; Woo J; Cockram CS; Chan JC
    Arch Intern Med; 2002 Nov; 162(21):2428-35. PubMed ID: 12437401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of orlistat on the total ghrelin and leptin levels in obese patients.
    Ozkan Y; Aydin S; Donder E; Koca SS; Aydin S; Ozkan B; Sahin I
    J Physiol Biochem; 2009 Sep; 65(3):215-23. PubMed ID: 20119816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of single-dose orlistat on postprandial serum glucose, insulin and glucagon-like peptide-1 levels in nondiabetic obese patients.
    Sahin M; Tanaci N; Yucel M; Tutuncu NB; Guvener N
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):346-50. PubMed ID: 17524030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
    Hill JO; Hauptman J; Anderson JW; Fujioka K; O'Neil PM; Smith DK; Zavoral JH; Aronne LJ
    Am J Clin Nutr; 1999 Jun; 69(6):1108-16. PubMed ID: 10357727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X.
    Reaven G; Segal K; Hauptman J; Boldrin M; Lucas C
    Am J Cardiol; 2001 Apr; 87(7):827-31. PubMed ID: 11274935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of orlistat on the fatty acid composition of serum lipid fractions in obese subjects.
    Vidgren HM; Agren JJ; Valve RS; Karhunen LJ; Rissanen AM; Uusitupa MI
    Clin Pharmacol Ther; 1999 Sep; 66(3):315-22. PubMed ID: 10511068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns.
    Karhunen L; Franssila-Kallunki A; Rissanen P; Valve R; Kolehmainen M; Rissanen A; Uusitupa M
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1567-72. PubMed ID: 11126207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss.
    Trouillot TE; Pace DG; McKinley C; Cockey L; Zhi J; Häeussler J; Guerciolini R; Showalter R; Everson GT
    Am J Gastroenterol; 2001 Jun; 96(6):1888-94. PubMed ID: 11421247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study.
    Drent ML; Larsson I; William-Olsson T; Quaade F; Czubayko F; von Bergmann K; Strobel W; Sjöström L; van der Veen EA
    Int J Obes Relat Metab Disord; 1995 Apr; 19(4):221-6. PubMed ID: 7627244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia.
    Micić D; Ivković-Lazar T; Dragojević R; Jorga J; Stokić E; Hajduković Z
    Med Pregl; 1999; 52(9-10):323-33. PubMed ID: 10624380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of orlistat on plasma lipids and body weight: A systematic review and meta-analysis of 33 randomized controlled trials.
    Sahebkar A; Simental-Mendía LE; Reiner Ž; Kovanen PT; Simental-Mendía M; Bianconi V; Pirro M
    Pharmacol Res; 2017 Aug; 122():53-65. PubMed ID: 28559211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orlistat inhibits dietary cholesterol absorption.
    Mittendorfer B; Ostlund RE; Patterson BW; Klein S
    Obes Res; 2001 Oct; 9(10):599-604. PubMed ID: 11595776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
    Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orlistat use in overweight women with mild hypercholesterolemia.
    Petrogiannopoulos C; Kalogeropoulos S; Latsios GS; Hartzoulakis G; Kalogeropoulos G; Zaharof A
    Int J Clin Pharmacol Res; 2002; 22(3-4):85-8. PubMed ID: 12837045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.